Afstyla Kit
Product Images NDC 69911-477

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Afstyla (NDC 69911-477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl Behring Lengnau Ag, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig. 1 (Afstyla 01)

FDA Label Image

Fig. 2 (Afstyla 02)

FDA Label Image

Fig. 3 (Afstyla 03)

FDA Label Image

Fig. 4 (Afstyla 04)

FDA Label Image

Fig. 5 (Afstyla 05)

FDA Label Image

Fig. 6 (Afstyla 06)

FDA Label Image

Fig. 7 (Afstyla 07)

FDA Label Image

Fig. 8 (Afstyla 08)

FDA Label Image

Fig. 1 (Afstyla 09)

FDA Label Image

Fig. 2 (Afstyla 10)

FDA Label Image

Fig. 3 (Afstyla 11)

FDA Label Image

Fig. 4 (Afstyla 12)

FDA Label Image

Fig. 5 (Afstyla 13)

FDA Label Image

Fig. 6 (Afstyla 14)

FDA Label Image

Fig. 7 (Afstyla 15)

FDA Label Image

Fig. 8 (Afstyla 16)

FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
This is a product description for AFSTYLA, a recombinant antihemophilic factor manufactured by CSL Behring. The product comes in powdered form and is administered intravenously. The text includes information regarding the product's manufacturing and distribution, as well as storage and dosage instructions.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Not available. The text seems to be a mix of random characters and words that do not make sense.*
FDA Label Image

Principal Display Panel (Kit Carton)

FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
This seems to be a description of the packaging and storage instructions for a medication called AFSTYLA, which is used as a treatment for hemophilia. The text includes information about the manufacturer, distributor, and contents of the medication, including dosage and administration instructions, expiration dates, and storage requirements. There are also some reference numbers and codes included.*
FDA Label Image

Principal Display Panel (Kit Carton)

FDA Label Image

Principal Display Panel (Kit Carton)

FDA Label Image

Principal Display Panel (Kit Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.